Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission

Glutamic acid decarboxylase of 65 kDa (GAD65) antibodies have been reported in a variety of neurological disorders such as stiff-person syndrome (SPS), sporadic ataxia and some cases of epilepsy. Since the target is believed to be the cytoplasmic enzyme GAD65, the key enzyme of γ-aminobutyric acid (...

Full description

Bibliographic Details
Main Authors: Hackert, Jana K., Müller, Lorenz, Rohde, Marco, Bien, Christian G., Köhling, Rüdiger, Kirschstein, Timo
Format: Online
Language:English
Published: Frontiers Media S.A. 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870265/
id pubmed-4870265
recordtype oai_dc
spelling pubmed-48702652016-05-30 Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission Hackert, Jana K. Müller, Lorenz Rohde, Marco Bien, Christian G. Köhling, Rüdiger Kirschstein, Timo Neuroscience Glutamic acid decarboxylase of 65 kDa (GAD65) antibodies have been reported in a variety of neurological disorders such as stiff-person syndrome (SPS), sporadic ataxia and some cases of epilepsy. Since the target is believed to be the cytoplasmic enzyme GAD65, the key enzyme of γ-aminobutyric acid (GABA) synthesis, the pathophysiological role of these antibodies is poorly understood. Here, we stereotactically injected human cerebrospinal fluid (CSF) containing GAD65-antibodies into the hippocampus of rats in vivo and then prepared hippocampal slices 1–2 days after post-operative recovery. We characterized both evoked and spontaneous GABAergic transmission in vitro using sharp microelectrode and patch-clamp recordings in CA1 neurons. Intracellular recordings with sharp microelectrodes from CA1 neurons showed that evoked GABAAR- or GABABR-mediated inhibitory postsynaptic potentials (IPSP) remained unaltered in anti-GAD65 tissue. These results were confirmed with patch-clamp recordings showing no difference in evoked gabazine-sensitive inhibitory postsynaptic currents (IPSCs). In addition, spontaneous IPSCs also showed no difference between anti-GAD65 tissue and controls with respect to the mean frequency, the mean amplitude and the sIPSC distribution. In conclusion, stereotactic injection of GAD65-antibodies into the hippocampus leaves evoked and spontaneous GABAergic synaptic transmission intact. Hence, dysfunction of the inhibitory GABAergic system does not appear to be the major mechanism of epileptogenicity in this disease. Frontiers Media S.A. 2016-05-18 /pmc/articles/PMC4870265/ /pubmed/27242441 http://dx.doi.org/10.3389/fncel.2016.00130 Text en Copyright © 2016 Hackert, Müller, Rohde, Bien, Köhling and Kirschstein. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Hackert, Jana K.
Müller, Lorenz
Rohde, Marco
Bien, Christian G.
Köhling, Rüdiger
Kirschstein, Timo
spellingShingle Hackert, Jana K.
Müller, Lorenz
Rohde, Marco
Bien, Christian G.
Köhling, Rüdiger
Kirschstein, Timo
Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission
author_facet Hackert, Jana K.
Müller, Lorenz
Rohde, Marco
Bien, Christian G.
Köhling, Rüdiger
Kirschstein, Timo
author_sort Hackert, Jana K.
title Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission
title_short Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission
title_full Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission
title_fullStr Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission
title_full_unstemmed Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission
title_sort anti-gad65 containing cerebrospinal fluid does not alter gabaergic transmission
description Glutamic acid decarboxylase of 65 kDa (GAD65) antibodies have been reported in a variety of neurological disorders such as stiff-person syndrome (SPS), sporadic ataxia and some cases of epilepsy. Since the target is believed to be the cytoplasmic enzyme GAD65, the key enzyme of γ-aminobutyric acid (GABA) synthesis, the pathophysiological role of these antibodies is poorly understood. Here, we stereotactically injected human cerebrospinal fluid (CSF) containing GAD65-antibodies into the hippocampus of rats in vivo and then prepared hippocampal slices 1–2 days after post-operative recovery. We characterized both evoked and spontaneous GABAergic transmission in vitro using sharp microelectrode and patch-clamp recordings in CA1 neurons. Intracellular recordings with sharp microelectrodes from CA1 neurons showed that evoked GABAAR- or GABABR-mediated inhibitory postsynaptic potentials (IPSP) remained unaltered in anti-GAD65 tissue. These results were confirmed with patch-clamp recordings showing no difference in evoked gabazine-sensitive inhibitory postsynaptic currents (IPSCs). In addition, spontaneous IPSCs also showed no difference between anti-GAD65 tissue and controls with respect to the mean frequency, the mean amplitude and the sIPSC distribution. In conclusion, stereotactic injection of GAD65-antibodies into the hippocampus leaves evoked and spontaneous GABAergic synaptic transmission intact. Hence, dysfunction of the inhibitory GABAergic system does not appear to be the major mechanism of epileptogenicity in this disease.
publisher Frontiers Media S.A.
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870265/
_version_ 1613580460114313216